Identification and Characterization of Small-Molecule Inhibitors of Yop Translocation in Yersinia pseudotuberculosis

被引:47
|
作者
Harmon, Dana E. [1 ]
Davis, Alison J. [1 ]
Castillo, Cynthia [1 ]
Mecsas, Joan [1 ]
机构
[1] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA
关键词
III PROTEIN SECRETION; ENTEROPATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; PSEUDOMONAS-AERUGINOSA; MAMMALIAN-CELLS; NEEDLE COMPLEX; VIRULENCE DETERMINANTS; BACTERIAL VIRULENCE; PLASMA-MEMBRANE; SUICIDE VECTOR;
D O I
10.1128/AAC.00364-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type three secretion systems (TTSSs) are virulence factors found in many pathogenic Gram-negative species, including the family of pathogenic Yersinia spp. Yersinia pseudotuberculosis requires the translocation of a group of effector molecules, called Yops, to subvert the innate immune response and establish infection. Polarized transfer of Yops from bacteria to immune cells depends on several factors, including the presence of a functional TTSS, the successful attachment of Yersinia to the target cell, and translocon insertion into the target cell membrane. Here we employed a high-throughput screen to identify small molecules that block translocation of Yops into mammalian cells. We identified 6 compounds that inhibited translocation of effectors without affecting synthesis of TTSS components and secreted effectors, assembly of the TTSS, or secretion of effectors. One compound, C20, reduced adherence of Y. pseudotuberculosis to target cells. Additionally, the compounds caused leakage of Yops into the supernatant during infection and thus reduced polarized translocation. Furthermore, several molecules, namely, C20, C22, C24, C34, and C38, also inhibited ExoS-mediated cell rounding, suggesting that the compounds target factors that are conserved between Pseudomonas aeruginosa and Y. pseudotuberculosis. In summary, we have identified 6 compounds that specifically inhibit translocation of Yops into mammalian cells but not Yop synthesis or secretion.
引用
收藏
页码:3241 / 3254
页数:14
相关论文
共 50 条
  • [41] Small-molecule inhibitors of histone acetyltransferase activity: Identification and biological properties
    Mai, Antonello
    Rotili, Dante
    Tarantino, Domenico
    Ornaghi, Prisca
    Tosi, Federica
    Vicidomini, Caterina
    Sbardella, Gianluca
    Nebbioso, Angela
    Miceli, Marco
    Altucci, Lucia
    Filetici, Patrizia
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) : 6897 - 6907
  • [42] Identification and characterization of small-molecule inducers of epidermal keratinocyte differentiation
    Hong, Jiyong
    Lee, Jongkook
    Min, Kyung Hoon
    Walker, John R.
    Peters, Eric C.
    Gray, Nathanael S.
    Cho, Charles Y.
    Schultz, Peter G.
    ACS CHEMICAL BIOLOGY, 2007, 2 (03) : 171 - 175
  • [43] Small-molecule inhibitors of carboxylesterase Notum
    Zhao, Yuguang
    Jolly, Sarah
    Benvegnu, Stefano
    Jones, E. Yvonne
    Fish, Paul, V
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (11) : 1001 - 1015
  • [44] Probing Translation with Small-Molecule Inhibitors
    Blanchard, Scott C.
    Cooperman, Barry S.
    Wilson, Daniel N.
    CHEMISTRY & BIOLOGY, 2010, 17 (06): : 633 - 645
  • [45] Discovery of small-molecule inhibitors of tyrosinase
    Germanas, Juris P.
    Wang, Shugauang
    Miner, Andrew
    Hao, Wayne
    Ready, Joseph M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (24) : 6871 - 6875
  • [46] Small-molecule allosteric inhibitors of BAX
    Thomas P. Garner
    Dulguun Amgalan
    Denis E. Reyna
    Sheng Li
    Richard N. Kitsis
    Evripidis Gavathiotis
    Nature Chemical Biology, 2019, 15 : 322 - 330
  • [47] Small-molecule allosteric inhibitors of BAX
    Garner, Thomas P.
    Amgalan, Dulguun
    Reyna, Denis E.
    Li, Sheng
    Kitsis, Richard N.
    Gavathiotis, Evripidis
    NATURE CHEMICAL BIOLOGY, 2019, 15 (04) : 322 - +
  • [48] Small-molecule inhibitors of myosin proteins
    Bond, Lisa M.
    Tumbarello, David A.
    Kendrick-Jones, John
    Buss, Folma
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (01) : 41 - 52
  • [49] Allosteric small-molecule kinase inhibitors
    Wu, Peng
    Clausen, Mads H.
    Nielsen, Thomas E.
    PHARMACOLOGY & THERAPEUTICS, 2015, 156 : 59 - 68
  • [50] Small-molecule direct thrombin inhibitors
    Wiley, MR
    Fisher, MJ
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (11) : 1265 - 1282